All Rights reserved, site designed by Yellohost.co.za
Credit: Anna Tarazevich from Pexels Results from a new study led by researchers at The …
Credit: Unsplash/CC0 Public Domain Despite significant improvements in data sharing for cancer clinical trials over …
Credit: CC0 Public Domain Eligibility requirements for clinical trials help protect patients whose comorbidities may …
Credit: CC0 Public Domain In a paper published in The Lancet Oncology, a research team …
Future Areas of Development for AlphaFold. We propose four areas of improvement for AlphaFold to …
Credit: Oncotarget (2024). DOI: 10.18632/oncotarget.28595 A new research perspective titled “Starving cancer cells to enhance …
Glofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) is superior to rituximab (R)-GemOx for relapsed/refractory (R/R) …
Credit: Unsplash/CC0 Public Domain Understanding the molecular characteristics of cancer that impact patient outcomes is …
Credit: Unsplash/CC0 Public Domain With around 1 in 50 adults diagnosed with cancer each year, …
Credit: Pixabay/CC0 Public Domain Transgender women are still at risk for prostate cancer. A new …
Credit: Pixabay/CC0 Public Domain The National Comprehensive Cancer Network (NCCN)—a nonprofit alliance of leading cancer …
Distribution of prostate-specific antigen (psa) values in relation to index clinical event (radical prostatectomy and …